Eli Lilly (LLY) Equity Average (2009 - 2026)
Eli Lilly posted quarterly Equity Average of $28.9 billion for Q1 2026, up 3082.08% year-on-year from $907.2 million in Q1 2025, and up 14.58% on a QoQ basis from $25.2 billion in Q4 2025.
Eli Lilly (LLY) has 18 years of Equity Average data on file, last reported at $28.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Equity Average rose 3082.08% year-over-year to $28.9 billion; the trailing twelve-month figure through Mar 2026 stood at $28.9 billion (up 3082.08% YoY), and the FY2025 full-year result was $13.4 billion, up 1067.87% from the prior year.
- Equity Average for Q1 2026 stood at $28.9 billion, up from $25.2 billion in the prior quarter.
- Across five years, Equity Average topped out at $28.9 billion in Q1 2026 and bottomed at -$4.3 billion in Q3 2022.
- The 5-year median for Equity Average is -$1.5 billion (2023), against an average of $2.0 billion.
- The widest annual swing landed in 2022, when Equity Average plunged 311.17%; it then soared 3176.62% in 2025.
- A 5-year view of Equity Average shows it stood at -$2.1 billion in 2022, then increased by 27.27% to -$1.5 billion in 2023, then surged by 46.45% to -$818.8 million in 2024, then jumped by 3176.62% to $25.2 billion in 2025, then increased by 14.58% to $28.9 billion in 2026.
- The last three Equity Average figures came in at $28.9 billion (Q1 2026), $25.2 billion (Q4 2025), and $11.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 28.87 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 81.37 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -4.96 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 49.27 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 8.92 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 23.11 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 88.29 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 19.27 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 19.67 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.87 Bn |
| Dec 31, 2025 | 25.19 Bn |
| Sep 30, 2025 | 11.90 Bn |
| Jun 30, 2025 | -1.12 Bn |
| Mar 31, 2025 | -968.00 Mn |
| Dec 31, 2024 | -818.85 Mn |
| Sep 30, 2024 | -905.10 Mn |
| Jun 30, 2024 | -2.11 Bn |
| Mar 31, 2024 | -3.66 Bn |
| Dec 31, 2023 | -1.53 Bn |
| Sep 30, 2023 | -965.15 Mn |
| Jun 30, 2023 | -2.83 Bn |
| Mar 31, 2023 | -1.84 Bn |
| Dec 31, 2022 | -2.10 Bn |
| Sep 30, 2022 | -4.29 Bn |
| Jun 30, 2022 | -4.26 Bn |
| Mar 31, 2022 | -4.28 Bn |
| Dec 31, 2021 | -4.40 Bn |
| Sep 30, 2021 | 2.03 Bn |
| Jun 30, 2021 | 2.76 Bn |
| Mar 31, 2021 | -4.75 Bn |
| Dec 31, 2020 | -6.53 Bn |
| Sep 30, 2020 | -2.98 Bn |
| Jun 30, 2020 | 20.60 Mn |
| Mar 31, 2020 | 3.06 Bn |
| Dec 31, 2019 | 6.65 Bn |
| Sep 30, 2019 | 6.57 Bn |
| Jun 30, 2019 | 1.36 Bn |
| Mar 31, 2019 | -1.94 Bn |
| Dec 31, 2018 | -23.90 Mn |
| Sep 30, 2018 | -1.50 Bn |
| Jun 30, 2018 | -3.64 Bn |
| Mar 31, 2018 | -2.25 Bn |
| Dec 31, 2017 | -719.90 Mn |
| Sep 30, 2017 | -2.11 Bn |
| Jun 30, 2017 | -4.02 Bn |
| Mar 31, 2017 | -2.62 Bn |
| Dec 31, 2016 | -1.54 Bn |
| Sep 30, 2016 | -1.41 Bn |
| Jun 30, 2016 | -524.30 Mn |
| Mar 31, 2016 | -533.20 Mn |
| Dec 31, 2015 | 7.63 Bn |
| Sep 30, 2015 | 14.97 Bn |
| Jun 30, 2015 | 14.83 Bn |
| Mar 31, 2015 | 15.16 Bn |
| Dec 31, 2014 | 16.52 Bn |
| Sep 30, 2014 | 17.83 Bn |
| Jun 30, 2014 | 18.16 Bn |
| Mar 31, 2014 | 17.98 Bn |
| Dec 31, 2013 | 17.26 Bn |
| Sep 30, 2013 | 16.07 Bn |
| Jun 30, 2013 | 15.10 Bn |
| Mar 31, 2013 | 14.86 Bn |
| Dec 31, 2012 | 15.41 Bn |
| Sep 30, 2012 | 15.18 Bn |
| Jun 30, 2012 | 14.57 Bn |
| Mar 31, 2012 | 14.18 Bn |
| Dec 31, 2011 | 14.30 Bn |
| Sep 30, 2011 | 14.67 Bn |
| Jun 30, 2011 | 14.11 Bn |
| Mar 31, 2011 | 13.18 Bn |
| Dec 31, 2010 | 12.41 Bn |
| Sep 30, 2010 | 11.32 Bn |
| Jun 30, 2010 | 10.35 Bn |
| Mar 31, 2010 | 5.28 Bn |
| Dec 31, 2009 | 5.00 Bn |
| Sep 30, 2009 | 9.23 Bn |